Asarone

Producers shown on SFDA

(Record date:09/10/2021）

Producers shown on EP

Not showing any

Producer:Changzhou Yabang Pharmaceutical Co., Ltd., established in October 2002, is located at No. 6, Liangchang East Road, Jintan Economic Development Zone, Changzhou City, Jiangsu Province, with a registered capital of 70 million yuan. Its business scope is the production and sales of chemical APIs. It is a subsidiary controlled by Jiangsu Yabang Pharmaceutical Group Co., Ltd.

The company covers an area of 80000 square meters, a construction area of 14000 square meters and a total investment of more than 100 million. It has 6 fine baking bag production lines, 5 synthesis workshops, 1 hydrogenation workshop, 1 testing center and 1 R & D center that meet the requirements of GMP, a set of sewage treatment devices and environmental protection facilities. The greening area is more than 40%, forming a professional company of 500 t / a API and pharmaceutical intermediates.

Staff size:200-299 persons   

Registered capital:RMB 70 million

Producer:Hainan Sha Ting Ning Pharmaceutical Co., Ltd., founded in 2015, has four workshops that meet the requirements of drug production and pass GMP certification. All production raw materials of the company have obtained and passed the GMP certification of the State Food and drug administration.

Staff size:50-99 persons

Registered capital:RMB 10 million

Producer:Lanxiha Medisan Pharmaceutical Co., Ltd., established in 2011, is a wholly-owned subsidiary of Harbin Medisan Pharmaceutical Co., Ltd. Harbin Medisan was built in 1996. In 2001, freeze-dried powder injection, small volume injection and large volume injection passed the national GMP certification at one time. The enterprise's production capacity and economic benefits increased rapidly.

Staff size:200-299 persons

Registered capital:RMB 440 million

Producer:Guangxi LMZ Yikang Pharmaceutical Co., Ltd. was founded in 1958. LMZ Yikang pharmaceutical has developed into a modern high-tech enterprise based on research and development and engaged in the production of medicine and related health products. The company's production center has first-class technical equipment, excellent technical personnel, strict and efficient management system and more than half a century of manufacturing experience. The products cover a wide range of fields, with a number of original or exclusive varieties and a number of national patents. The business covers 24 provinces in China and has won the trust and praise of consumers with superior quality.

Staff size:200-299 persons

Registered capital:RMB 91 million

Producer:Founded in 2001, Jiangsu Gibier pharmaceutical Co., Ltd. has 115 existing products. It has the research and development, production capacity, pre processing and extraction capabilities of tablets, hard capsules, eye drops, gel, cream and other formulations and products, and takes Leucogen Tablets, Yuping wind capsules, Aceclofenac Enteric-Coated Tablets, etc. Nitranolol tablets and other high-tech products are diversified product series. The product functions cover many treatment fields such as improving leukocyte, enhancing immunity, treating joint diseases, anti hypertension, anti eye infection, treating bronchitis and protecting liver function. It is committed to developing drugs for treating depression, tumor, stomach disease and other diseases, To meet market and clinical needs.
Staff size:/

Registered capital:186 million 900 thousand

Producer:Penglai Nuokang Pharmaceutical Co., Ltd. was established in 2002, with a total area of 69 thousand square meters. It has a modern R & D center laboratory with 41 thousand square meters and more than 1100 square meters in line with the requirements of the national GMP, and 7 production workshops. It has freeze-dried powder injection, small volume injection, tablet, granule, hard capsule, aerosol, spray. The scale production capacity of 12 modern production lines such as chemical raw materials and biochemical raw materials and more than 70 production varieties of various dosage forms, with an annual production of 72 million lyophilized powder injections and 45 million small volume injections; There were 250 million tablets, 50 million granules, 40 million capsules, 6 million aerosol and 6 million bottles of sprays.

Staff size:200-299 persons
Registered capital:RMB 92.7117 million

For supply and market information, please feel free to contact Mr. Paul, paulzhang@yinuopharmchem.com, WhatsApp: +86 18402846978